INDIVIDUALIZATION OF TREATMENT OF PATIENTS WITH CEREBRAL METASTASES OF MALIGNANT TUMORS. PROGNOSTIC SCALE TUNS
https://doi.org/10.18027/2224-5057-2017-7-4-48-52
Abstract
Improvement in the diagnosis and treatment of cancer patients, increase in frequency of prevalence and detection of metastatic lesions of the brain make the choice of treatment timely and important. The article presents data on the current prognostic scales for patients with cerebral metastases of solid tumors and the analysis of their features. The features of choice of tactics and strategy of treatment of patients with cerebral metastases of solid tumors depending on various prognostic factors are described. The original version of the rating scale for determining treatment options for patients with metastatic brain lesions is proposed. We suggest to consider oncological, neurological (neurosurgical), somatic (functional) groups of factors to choose the tactics of treatment of patients with brain metastases.
About the Authors
V. A. Aleshin
N. N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
Vladimir A. Aleshin - PhD, Research Scientist, Neurosurgery Department.
Moscow
A. H. Bekyashev
N. N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
Ali Kh. Bekyashev - Professor, MD, Head of the Neurosurgery Department.
Moscow
D. M. Belov
N. N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
Dmitriy M. Belov - MD, PhD, Research Scientist, Neurosurgery Department.
Moscow
A. V. Zotov
N. N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
Andrey V. Zotov - MD, PhD, Anesthesiology Department.
Moscow
V. B. Karahan
N. N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
Vladislav B. Karahan, professor, MD, Leading Researcher, Neurosurgery Department.
Moscow
D. R. Naskhletashvili
N. N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
David R. Naskhletashvili, PhD, Senior Research Scientist, Neurosurgery Department.
Moscow
E. V. Prozorenko
I.M. Sechenov First Moscow State Medical University
Evgeniy V. Prozorenko, PhD, Assistant Professor.
Moscow
References
1. Torre L.A., Siegel R. L., Ward E.M., Jemal A. Global Cancer Incidence and Mortality Rates and Trends--An Update, Cancer Epidemiol. Biomarkers Prev., 2016 Jan, Vol. 25 (1), pp. 16–27.
2. Голанов А.В., Банов С.М., Ильялов С.Р., Трунин Ю.Ю., Маряшев С.А., Ветлова Е.Р., Осинов И.К., Костюченко В.В., Далечина А.В., Дургарян А.А. Радиохирургическое лечение метастазов в головной мозг. Факторы прогноза общей выживаемости и интракраниальных рецидивов. Вопросы нейрохирургии им. Н.Н. Бурденко. – 2016. Т. 80. №2. С. 35–46. [Golanov A.V., Banov S.M., Il’yalov S. R., Trunin Yu.Yu., Maryashev S.A., Vetlova E.R., Osinov I.K., Kostyuchenko V.V., Dalechina A.V., Durgaryan A.A. Radiokhirurgicheskoe lechenie metastazov v golovnoi mozg. Faktory prognoza obshchei vyzhivaemosti i intrakranial’nykh retsidivov, Voprosy neirokhirurgii im. N.N. Burdenko, 2016, Vol. 80, No. 2, pp. 35–46 (In Russ.)].
3. Измайлов, Т. Р., Даценко П.В., Паньшин Г.А. Адаптированный вариант классификации RPA при лечении глиом высокой степени злокачественности (часть 1). Вестник Российского научного центра рентгенорадиологии Федерального агентства по высокотехнологичной медицинской помощи. 2011. №3. С. 31–42. [Izmailov T.R., Datsenko P.V., Pan’shin G.A. Adaptirovannyi variant klassifikatsii RPA pri lechenii gliom vysokoi stepeni zlokachestvennosti (chast’ 1), Vestnik Rossiiskogo nauchnogo tsentra rentgenoradiologii Federal’nogo agentstva po vysokotekhnologichnoi meditsinskoi pomoshchi, 2011, No. 3, pp. 31–42 (In Russ.)].
4. Sperduto P.W., Kased N., Roberge D. et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosisspecific tool to estimate survival for patients with brain metastases, J. Clin. Oncol., 2012 Feb 1, Vol. 30 (4), pp. 419–425.
5. Gaspar L. Scott C, Rotman M. et al., Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials, Int. J. Radiat. Oncol. Biol. Phys., 1997 Mar 1, Vol. 37 (4), pp. 745–751.
6. Ruda R., Franchino F., Soffietti R. Treatment of brain metastasis: current status and future directions, Curr. Opin. Oncol., 2016 Nov, Vol. 28 (6), pp. 502–510.
7. Карахан В.Б., Алешин В.А., Фу Р. Г., Крат В.Б. Одномоментное удаление двух метастазов рака легкого из разных областей головного мозга. Современная Онкология. 2005. Том 7. № 2. С. 66–68. [Karakhan V.B., Aleshin V.A., Fu R.G., Krat V.B. Odnomomentnoe udalenie dvukh metastazov raka legkogo iz raznykh oblastei golovnogo mozga, Sovremennaya Onkologiya, 2005, Vol. 7, No. 2, pp. 66–68 (In Russ.)].
8. Vaca S.D., Connolly I.D., Ho C., Neal J. et al. Commentary: Treatment Considerations for Patients With Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Brain Metastases in the Era of Tyrosine Kinase Inhibitors, Neurosurgery, 2017 Aug 12, PMID: 28945866.
9. Wilkins A., Furness A., Corbett R.W. et al. The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma, Br. J. Cancer, 2015 Nov, Vol. 113 (9), pp. 127–181.
10. Nieder C. et al. Diagnosis-specificgraded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries, Med.Sci. Monit., 2012, Vol. 18 (7), pp. CR450 – CR455.
11. Алешин В.А., Белов Д.М., Карахан В.Б., Бекяшев А.Х. Нейрохирургические вмешательства у пациентов с метастазами рака легкого в головной мозг: факторы, влияющие на прогноз. Вестник РОНЦ им. Н.Н. Блохина. 2016. Том 27. №2. С. 103–107. [Aleshin V.A., Belov D.M., Karakhan V.B., Bekyashev A.Kh. Neirokhirurgicheskie vmeshatel’stva u patsientov s metastazami raka legkogo v golovnoi mozg: faktory, vliyayushchie na prognoz, Vestnik RONTs im. N.N. Blokhina, 2016, Vol. 27, No. 2, pp. 103–107 (In Russ)].
Review
For citations:
Aleshin V.A., Bekyashev A.H., Belov D.M., Zotov A.V., Karahan V.B., Naskhletashvili D.R., Prozorenko E.V. INDIVIDUALIZATION OF TREATMENT OF PATIENTS WITH CEREBRAL METASTASES OF MALIGNANT TUMORS. PROGNOSTIC SCALE TUNS. Malignant tumours. 2017;7(4):48-52. (In Russ.) https://doi.org/10.18027/2224-5057-2017-7-4-48-52
Views:
1019
Email this article 